Both in Pharmaceuticals
ANI Pharmaceuticals vs Supernus
Over the past year ANIP returned −23.3% and SUPN returned −51.0%; their daily moves had a correlation of 0.22.
ANIP −23.3% SUPN −51.0%Growth of $1, one year, split-adjusted
| Metric | ANIP | SUPN |
|---|---|---|
| Price | $72.16 | $27.28 |
| Market cap | $1.66B | $1.59B |
| Today | −0.17% | −3.09% |
| 1 month | +0.9% | −36.3% |
| 6 months | −14.2% | −47.0% |
| Year to date | −8.6% | −45.1% |
| 1 year | −23.3% | — |
| Revenue growth (YoY) | +25.9% | +18.0% |
| Gross margin | 62.4% | 88.1% |
| Net margin | 8.6% | 9.2% |
| P/E (TTM) | 16.6× | — |
| Price / sales | 1.7× | 1.8× |
| Net cash | -$234.7M | $359.5M |
| Dividend yield | — | 29.80% |
| Volatility (60d) | 26.7% | 86.1% |
| Short % of float | 18.1% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).